Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

CD8+ CD28 null T Cell Expansion Impairs Lenalidomide Immunomodulatory Function in Myelodysplastic Syndrome

Jessica M. McDaniel, BS, JianXiang Zou, MD, Alan F. List, MD, P.K. Epling-Burnette, PharmD, PhD

Blood (2011) 118 (21): 1117.

https://doi.org/10.1182/blood.V118.21.1117.1117

Published: 2011

Journal Articles

Autoproliferation Contributes to Clonal Expansion and Changes In Cellular Topography In T Cell Large Granular Lymphocyte (LGL) Leukemia

JianXiang Zou, MD, Jeffrey S Painter, BS, Fanqi Bai, MD, Lubomir Sokol, MD, PhD, Thomas P. Loughran, Jr., MD, P.K. Epling-Burnette, PharmD, PhD

Blood (2010) 116 (21): 1373.

https://doi.org/10.1182/blood.V116.21.1373.1373

Published: 2010

Journal Articles

Functional T Cell Array Reveals Pre-Treatment Expanded Terminal Effector Memory Response Is Associated with Lenalidomide Failure in Non-Del(5q) Myelodysplastic Syndrome.

P.K. Epling-Burnette, PhD, JianXiang Zou, MD, Jeffrey S. Painter, B.S., Dung-Tsa Chen, Jimmy Fulp, Rami S. Komrokji, MD, Sheng Wei, MD, Alan F List, MD

Blood (2009) 114 (22): 1759.

https://doi.org/10.1182/blood.V114.22.1759.1759

Published: 2009

Journal Articles

Pathogenetic Role of Impaired Telomere Repair in Myelodysplastic Syndrome.

P.K. Epling-Burnette, PhD, Alan F List, MD, Justine Clark, MS, Ji-Hyun Lee, Kristen A. Jonathan, William Fulp, Xiaohong Li, Weipeng Zheng, Jeffrey S. Painter, B.S., JianXiang Zou, MD, Rami S. Komrokji, MD, Sheng Wei, MD, Jong Park, Amber Schmidt, Undergraduate, student, Chiharu Sugimori, MD, Ashley Cole, Dana E Rollison, PhD

Blood (2009) 114 (22): 2777.

https://doi.org/10.1182/blood.V114.22.2777.2777

Published: 2009

Journal Articles

Co-Existance of JAK V617F and PIG-A mutations in Primary Budd-Chiari Syndrome.

Chiharu Sugimori, MD, Kenneth H Shain, MD, PhD, Gisela Caceres, PhD, Lubomir Sokol, MD, PhD, David Araten, MD, Jaroslaw P. Maciejewski, MD, PhD, JianXiang Zou, MD, P.K. Epling-Burnette, PhD, Alan F List, MD

Blood (2009) 114 (22): 3193.

https://doi.org/10.1182/blood.V114.22.3193.3193

Published: 2009

Journal Articles

Altered Naive and Memory T Cell Homeostasis and Immunosenescence Characterize Younger Patients with Immunosuppressive-Responsive Myelodysplastic Syndrome

JianXiang Zou, MD, Dana E Rollison, PhD, David Boulware, MS, Elaine M. Sloand, MD, Loretta Pfannes, BS, Fanqi Bai, MD, Jeffrey S. Painter, BS, Sheng Wei, MD, Denise Cosgrove, RN, Alan F. List, MD, P.K. Epling-Burnette, PhD

Blood (2008) 112 (11): 3647.

https://doi.org/10.1182/blood.V112.11.3647.3647

Published: 2008

Journal Articles

Dysregulated Distribution of Naïve and Memory FoxP3 Positive Regulatory T-Cells Associated with Anemia in Myelodysplastic Syndrome (MDS)

Chiharu Sugimori, MD, JianXiang Zou, MD, Christine O’Keefe, PhD, Michael Clemente, MS, Tie-Ying Wei, BS, Jaroslaw Maciejewski, Thomas P. Loughran, Jr., MD, Ron Paquette, MD, Alan F. List, MD, P.K. Epling-Burnette, PhD

Blood (2008) 112 (11): 3654.

https://doi.org/10.1182/blood.V112.11.3654.3654

Published: 2008

Journal Articles

First Clinical Report of Tipifarnib for the Treatment of T-Large Granular Lymphocyte (LGL) Leukemia.

P.K. Epling-Burnette, PhD, Lubomir Sokol, MD, Lynn Moscinski, MD, Magda Elkabani, MD, Fanqi Bai, MD, Michelle Blaskovich, BS, JianXiang Zou, MD, Jeffrey S. Painter, BS, Said Sebti, PhD, Thomas P. Loughran, MD

Blood (2007) 110 (11): 3132.

https://doi.org/10.1182/blood.V110.11.3132.3132

Published: 2007

Journal Articles

Reduced Natural Killer Function Accompanies MDS Disease Progression and Is Restored by Lenalidomide (CC5013, Revlimid®) Via a Mechanism Divergent from Interleukin-2 (IL-2).

P.K. Epling-Burnette, PhD, Fanqi Bai, MD, Jeffrey S. Painter, BS, Rollison Dana, PhD, JianXiang Zou, MD, Edna Ku, MD, Bin Zhong, BS, Sheng Wei, MD, Julie Y. Djeu, PhD, Alan F. List, MD

Blood (2006) 108 (11): 2651.

https://doi.org/10.1182/blood.V108.11.2651.2651

Published: 2006

Journal Articles

Lenalidomide (CC5013, Revlimid®) Promotes T Helper-1 Function Bias and Increases Responsiveness to Autologous Bone Marrow Antigens in Myelodysplastic Syndrome (MDS).

Edna Ku, MD, PhD, JianXiang Zou, MD, Fanqi Bai, MD, Jeffrey S. Painter, BS, Alan F. List, MD, P.K. Epling-Burnette, PhD

Blood (2006) 108 (11): 2659.

https://doi.org/10.1182/blood.V108.11.2659.2659

Published: 2006

Journal Articles

Lenalidomide (CC5013, Revlimid®) Alters a T Cell Homeostatic Check-Point in Patients with Myelodysplastic Syndrome (MDS).

JianXiang Zou, MD, Edna Ku, MD, PhD, Fanqi Bai, MD, Jeffrey S. Painter, BS, Alan F. List, MD, P.K. Epling-Burnette, PhD

Blood (2006) 108 (11): 851.

https://doi.org/10.1182/blood.V108.11.851.851

Published: 2006

Journal Articles

Complex Immunosuppressive Action of Farnesyltransferase Inhibitor (FTI) R115777 (Tipifarnib, Zarnestra®) with Induction of Apoptosis in T Cells from Patients with Large Granular Lymphocyte (LGL) Leukemia.

Fanqi Bai, MD, JianXiang Zou, MD, Jun Yang, MD, Edna Ku, MD,PhD, Sheng Wei, MD, Thomas P. Loughran, MD, P.K. Epling-Burnette, PhD

Blood (2006) 108 (11): 4960.

https://doi.org/10.1182/blood.V108.11.4960.4960

Published: 2006

Journal Articles

T Large Granular Lymphocyte (LGL) Leukemia Characterized by Expansion of Terminal CD3+/CD8+/CD62L−/CD45RA+ Effector Memory T Cells.

JianXiang Zou, MD, Jeffrey S. Painter, BS, Fanqi Bai, MD, Thomas P. Loughran, MD, P.K. Epling-Burnette, PhD

Blood (2006) 108 (11): 4962.

https://doi.org/10.1182/blood.V108.11.4962.4962

Published: 2006

NARROW

CD8+ CD28 null T Cell Expansion Impairs Lenalidomide Immunomodulatory Function in Myelodysplastic Syndrome

Autoproliferation Contributes to Clonal Expansion and Changes In Cellular Topography In T Cell Large Granular Lymphocyte (LGL) Leukemia

Functional T Cell Array Reveals Pre-Treatment Expanded Terminal Effector Memory Response Is Associated with Lenalidomide Failure in Non-Del(5q) Myelodysplastic Syndrome.

Pathogenetic Role of Impaired Telomere Repair in Myelodysplastic Syndrome.

Co-Existance of JAK V617F and PIG-A mutations in Primary Budd-Chiari Syndrome.

Altered Naive and Memory T Cell Homeostasis and Immunosenescence Characterize Younger Patients with Immunosuppressive-Responsive Myelodysplastic Syndrome

Dysregulated Distribution of Naïve and Memory FoxP3 Positive Regulatory T-Cells Associated with Anemia in Myelodysplastic Syndrome (MDS)

First Clinical Report of Tipifarnib for the Treatment of T-Large Granular Lymphocyte (LGL) Leukemia.

Reduced Natural Killer Function Accompanies MDS Disease Progression and Is Restored by Lenalidomide (CC5013, Revlimid®) Via a Mechanism Divergent from Interleukin-2 (IL-2).

Lenalidomide (CC5013, Revlimid®) Promotes T Helper-1 Function Bias and Increases Responsiveness to Autologous Bone Marrow Antigens in Myelodysplastic Syndrome (MDS).

Lenalidomide (CC5013, Revlimid®) Alters a T Cell Homeostatic Check-Point in Patients with Myelodysplastic Syndrome (MDS).

Complex Immunosuppressive Action of Farnesyltransferase Inhibitor (FTI) R115777 (Tipifarnib, Zarnestra®) with Induction of Apoptosis in T Cells from Patients with Large Granular Lymphocyte (LGL) Leukemia.

T Large Granular Lymphocyte (LGL) Leukemia Characterized by Expansion of Terminal CD3+/CD8+/CD62L−/CD45RA+ Effector Memory T Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only